The impact of regulatory T lymphocytes on long-term survival in patients with ischemic heart failure with reduced ejection fraction

被引:0
|
作者
Sulzgruber, Patrick [1 ]
Koller, L. [1 ]
Blum, S. [1 ]
Huelsmann, M. [1 ]
Wojta, J. [1 ]
Niessner, A. [1 ]
机构
[1] Med Univ Vienna, Cardiol, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P262
引用
收藏
页码:43 / 43
页数:1
相关论文
共 50 条
  • [21] Tolvaptan Improves the Long-Term Prognosis in Patients With Congestive Heart Failure With Preserved Ejection Fraction as Well as in Those With Reduced Ejection Fraction
    Imamura, Teruhiko
    Kinugawa, Koichiro
    INTERNATIONAL HEART JOURNAL, 2016, 57 (05) : 600 - 606
  • [22] Clinical predictors of the long-term progression of renal dysfunction in heart failure patients with reduced ejection fraction
    Ural, D. Dilek
    Argan, O.
    Karauzum, K.
    Karauzum, I.
    Kozdag, G.
    Agir, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 250 - 250
  • [23] Clinical Characteristics and Long-term Prognosis in Patients with Chronic Heart Failure and Reduced Ejection Fraction in China
    Liu, Xiaoyan
    Yu, Haiyun
    Pei, Juanhui
    Chu, Jianmin
    Pu, Jielin
    Zhang, Shu
    HEART LUNG AND CIRCULATION, 2014, 23 (09): : 818 - 826
  • [24] Baroreflex activation therapy in heart failure patients with reduced ejection fraction: a long-term follow up
    Wang, D.
    Mueller-Leisse, J.
    Hillmann, H. A. K.
    Eiringhaus, J.
    Berliner, D.
    Karfoul, N.
    Schmitto, J. D.
    Ruhparwar, A.
    Bauersachs, J.
    Duncker, D.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [25] Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction
    Gronda, Edoardo
    Seravalle, Gino
    Trevano, Fosca Quarti
    Costantino, Giuseppe
    Casini, Andrea
    Alsheraei, Ali
    Lovett, Eric G.
    Vanoli, Emilio
    Mancia, Giuseppe
    Grassi, Guido
    JOURNAL OF HYPERTENSION, 2015, 33 (08) : 1704 - 1708
  • [26] Left atrial reservoir strain and long-term prognosis in patients with heart failure and reduced ejection fraction
    Chimed, S.
    Stassen, J.
    Galloo, X.
    Meucci, M. C.
    Van der Bijl, P.
    Marsan, N. A.
    Delgado, V.
    Bax, J. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 926 - 926
  • [27] Long-term outcomes in patients with critical limb ischemia and heart failure with preserved or reduced ejection fraction
    Khaira, Kavita B.
    Brinza, Ellen
    Singh, Gagan D.
    Amsterdam, Ezra A.
    Waldo, Stephen W.
    Tong, Kathleen
    Pandya, Kruti
    Laird, John R.
    Armstrong, Ehrin J.
    VASCULAR MEDICINE, 2017, 22 (04) : 307 - 315
  • [28] Impact of drug therapy on long-term prognosis in patients with ischemic chronic heart failure with preserved ejection fraction and renal dysfunction
    Lashkul, D. A.
    ZAPOROZHYE MEDICAL JOURNAL, 2016, (05) : 20 - 24
  • [29] Precipitating factors for heart failure decompensations and long-term mortality in severe chronic heart failure reduced ejection fraction patients
    Mewton, N. Nathan
    Donal, E.
    Grinberg, D.
    Picard, F.
    Derimay, F.
    Rouleau, F.
    Obadia, J. F.
    Maucort-Boulch, D.
    Trochu, J. N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 37 - 38
  • [30] Effect of atrial fibrillation on long-term survival in patients hospitalized for heart failure with preserved ejection fraction
    Rusinaru, D.
    Leborgne, L.
    Peltier, M.
    Tribouilloy, C.
    EUROPEAN HEART JOURNAL, 2008, 29 : 290 - 290